sq-11725 has been researched along with betadex in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, S; Kondo, H; Takahashi, Y; Watanabe, T; Yasuda, T; Yokohama, S | 1 |
| Ching, CB; Wang, X | 1 |
2 other study(ies) available for sq-11725 and betadex
| Article | Year |
|---|---|
Common solubilizers to estimate the Caco-2 transport of poorly water-soluble drugs.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Caco-2 Cells; Cell Survival; Cyclodextrins; Dextrans; Excipients; Fluorescein-5-isothiocyanate; Humans; Intestinal Absorption; Nadolol; Permeability; Polyethylene Glycols; Polysorbates; Propranolol; Propylene Glycol; Solubility; Solvents | 2002 |
Liquid chromatographic retention behavior and enantiomeric separation of three chiral center beta-blocker drug (nadolol) using heptakis (6-azido-6-deoxy-2, 3-di-O-phenylcarbamolyted) beta-cyclodextrin bonded chiral stationary phase.
Topics: Adrenergic beta-Antagonists; beta-Cyclodextrins; Chromatography, High Pressure Liquid; Cyclodextrins; Hydrogen-Ion Concentration; Nadolol; Osmolar Concentration; Stereoisomerism; Temperature | 2002 |